June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Expression of Inflammatory Mediators in Eyes of Spontaneously Type-2 Diabetic Monkeys
Author Affiliations & Notes
  • Imran Bhutto
    Ophthalmology, Johns Hopkins Hosp Wilmer Eye Inst, Baltimore, MD
  • Joseph Yates
    Ophthalmology, Johns Hopkins Hosp Wilmer Eye Inst, Baltimore, MD
  • Mary Johnson
    Ophthalmology, University of Maryland School of Medicine, Baltimore, MD
  • Carol Merges
    Ophthalmology, Johns Hopkins Hosp Wilmer Eye Inst, Baltimore, MD
  • Barbara Hansen
    Internal Medicine and Pediatrics, University of South Florida, Tampa, FL
  • Gerard Lutty
    Ophthalmology, Johns Hopkins Hosp Wilmer Eye Inst, Baltimore, MD
  • Footnotes
    Commercial Relationships Imran Bhutto, None; Joseph Yates, None; Mary Johnson, None; Carol Merges, None; Barbara Hansen, CrownBiosciences (C), Xoma (C), Merck (C); Gerard Lutty, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2686. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Imran Bhutto, Joseph Yates, Mary Johnson, Carol Merges, Barbara Hansen, Gerard Lutty; Expression of Inflammatory Mediators in Eyes of Spontaneously Type-2 Diabetic Monkeys. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2686. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Diabetic retinopathy (DR) is a chronic complication of diabetes, characterized by degeneration of neurons and glial activation accompanied by diffuse vascular abnormalities. However, the mechanisms of vascular pathology in DR are not yet fully understood but increasing evidence indicates that inflammation plays a key role in the pathogenesis of DR. The increased expression of adhesion molecules and inflammatory cytokines, as well as microglial activation in the retina or vitreous, all suggest that local inflammation may represent the central pathway leading to DR. In the present study, we examined the expression and localization of inflammatory mediators in spontaneously diabetic and nondiabetic rhesus monkey eyes.

Methods: Eyes from 9 spontaneously type-2 diabetic and 8 normotensive non-diabetic rhesus monkeys were evaluated. Alkaline phosphatase immunohistochemistry was performed using monoclonal and/or polyclonal antibodies against inflammatory mediators on cryopreserved sections from disk/macular blocks. Pigment in retinal pigment epithelium (RPE) and choroidal melanocytes was bleached. Three independent masked observers scored the reaction product (scored from 0-8). Mean scores from the diabetic and the eyes with non-diabetes were analyzed using 1-way analysis of variance and unpaired Student t-test.

Results: The expression of ICAM-1, TNF-α, VEGF, CRP, and MCP-1 was significantly higher in retinal and choroidal blood vessels in diabetic monkeys and were associated with severity of diabetes. ICAM-1 was significantly higher in neural retina (p≤0.02) of diabetic eyes and ICAM-1, TNF-α, and VEGF were significantly higher in RPE of diabetic than nondiabetic monkey eyes. IL-6 was more intense and significantly higher in Bruchs membrane/choriocapillaris complex (BrM/CC) (p≤0.045) including intercapillary septa (ICS) (p≤0.009) in diabetic monkey choroids. IP-10 was more prominent in melanocytes in diabetic choroids (p≤0.03). The number of MHCII positive cells was significantly higher in diabetic monkey choroids.

Conclusions: These immunohistochemical findings showed an increased expression and relative levels of inflammatory mediators in diabetic monkey eyes. These data support the role of inflammation in the pathogenesis of type 2 diabetes. Targeting a combination of proinflammatory mediators, simultaneously, may be an effective strategy for the treatment of diabetic retinopathy.

Keywords: 557 inflammation • 499 diabetic retinopathy • 554 immunohistochemistry  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.